Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
354 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02175381 | Carboplatin Plus Gemcitabine for Elderly Patients With Stage IV NSCLC | completed | Phase 1 / Phase 2 | 69 | Hellenic Oncology Research GroupOTHER | 1 | May 15, 2015 | clinicaltrials |
| NCT01500720 | Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer | completed | Phase 2 | 179 | SanofiINDUSTRY | 16 | Apr 13, 2015 | clinicaltrials |
| NCT01215539 |
| Study of Panitumumab-Capecitabine-Oxaliplatin In Wild-Type K-Ras Metastatic Colorectal Cancer Patients |
| completed |
| Phase 2 |
| 78 |
| Hellenic Cooperative Oncology GroupOTHER |
| 1 |
| Mar 18, 2015 |
| clinicaltrials |
| NCT00832234 | Bortezomib, Dexamethasone, and Rituximab in Untreated Waldenstroms Macroglobulinemia(BDR-WM) | completed | Phase 2 | 59 | European Myeloma Network B.V.NETWORK | 1 | Feb 18, 2015 | clinicaltrials |
| NCT00661011 | Lobectomy and Mediastinal Radiochemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer Responding to Induction Chemotherapy | terminated | Phase 2 | 75 | European Lung Cancer Working PartyOTHER | 3 | Feb 12, 2015 | clinicaltrials |
| NCT00652366 | A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer | completed | Phase 2 | 467 | Hoffmann-La RocheINDUSTRY | 23 | Feb 11, 2015 | clinicaltrials |
| NCT00908232 | Treatment With Velcade (Bortezomib) Plus Dexamethasone (VD) or VD Plus Cyclophosphamide or VD Plus Lenalidomide in Patients With Multiple Myeloma Stabilized After 4 Cycles of VD(SEQUENTIAL) | completed | Phase 2 | 163 | Janssen-Cilag International NVINDUSTRY | 10 | Jan 15, 2015 | clinicaltrials |
| NCT01218529 | Lapatinib and WBRT for Patients With Brain Metastases From Lung or Breast Tumors | completed | Phase 2 | 82 | Hellenic Cooperative Oncology GroupOTHER | 1 | Dec 31, 2014 | clinicaltrials |
| NCT00044525 | Evaluation of BAY59-8862 in Taxane-Resistant Metastatic Breast Cancer Patients | completed | Phase 2 | 82 | BayerINDUSTRY | 7 | Dec 23, 2014 | clinicaltrials |
| NCT00576758 | GAUSS: A Study of Obinutuzumab (RO5072759) in Patients With Indolent Non-Hodgkin's Lymphoma | completed | Phase 2 | 175 | Hoffmann-La RocheINDUSTRY | 17 | Aug 19, 2014 | clinicaltrials |
| NCT00125034 | Oxaliplatin and Cetuximab in First-line Treatment of Metastatic Colorectal Cancer (mCRC)(OPUS) | completed | Phase 2 | 344 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 13 | Aug 7, 2014 | clinicaltrials |
| NCT00972959 | Effect of Combination of Bortezomib/Dexamethasone/Zoledronic Acid on Bone Disease in Patients With Multiple Myeloma Relapsed After 1-3 Prior Lines of Therapy | completed | Phase 2 | 17 | University of AthensOTHER | 1 | Aug 5, 2014 | clinicaltrials |
| NCT01362296 | An Open-label Study of GSK1120212 Compared With Docetaxel in Stage IV KRAS-mutant Non-small Cell Lung Cancer | completed | Phase 2 | 134 | GlaxoSmithKlineINDUSTRY | 8 | Jul 11, 2014 | clinicaltrials |
| NCT00439517 | Study to Evaluate the Efficacy and Safety of FOLFOX-4 Plus Cetuximab Versus UFOX Plus Cetuximab.(FUTURE) | completed | Phase 2 | 302 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 14 | Jun 27, 2014 | clinicaltrials |
| NCT00620971 | Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLC | completed | Phase 2 | 77 | Hellenic Oncology Research GroupOTHER | 1 | Jun 25, 2014 | clinicaltrials |
| NCT00423124 | Infusion of Donor Lymphocytes Transduced With the Suicide Gene HSV TK in Patients With Haematological Malignancies | completed | Phase 1 / Phase 2 | 57 | AGC Biologics S.p.A.INDUSTRY | 5 | May 30, 2014 | clinicaltrials |
| NCT00431769 | An Efficacy and Safety Study of Bortezomib Re-treatment in Multiple Myeloma | completed | Phase 2 | 130 | Janssen-Cilag International NVINDUSTRY | 8 | May 12, 2014 | clinicaltrials |
| NCT00707889 | Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer | completed | Phase 2 | 159 | AbbVie (prior sponsor, Abbott)INDUSTRY | 14 | May 15, 2013 | clinicaltrials |
| NCT00564720 | Gemcitabine Plus Erlotinib Versus Erlotinib Plus Gemcitabine Plus Oxaliplatin, in Pancreatic Cancer | terminated | Phase 2 | 140 | Hellenic Oncology Research GroupOTHER | 1 | Feb 15, 2013 | clinicaltrials |
| NCT00431795 | Randomized Phase II Study of Epirubicin vs Caelyx in Pretreated Metastatic Breast Cancer | terminated | Phase 2 | 100 | Hellenic Oncology Research GroupOTHER | 1 | Feb 13, 2013 | clinicaltrials |
| NCT00681876 | Phase II Study of Avastin + Erbitux + Irinotecan as 2nd Line Treatment of Colorectal Cancer | terminated | Phase 2 | 16 | Hellenic Oncology Research GroupOTHER | 1 | Feb 13, 2013 | clinicaltrials |
| NCT00705549 | Individualized Therapy Based of Tumoral mRNA Levels of ERCC1, RRM1 and BRCA1 in Advanced Non-Small-Cell Lung Cancer | terminated | Phase 2 | 88 | Hellenic Oncology Research GroupOTHER | 1 | Feb 13, 2013 | clinicaltrials |
| NCT00755534 | Irinotecan/Cetuximab Followed by XELOX/Cetuximab vs the Reverse Sequence in Metastatic CRC | terminated | Phase 2 | 68 | Hellenic Oncology Research GroupOTHER | 1 | Feb 13, 2013 | clinicaltrials |
| NCT00558103 | Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer | completed | Phase 2 | 163 | GlaxoSmithKlineINDUSTRY | 28 | Feb 4, 2013 | clinicaltrials |
| NCT00297089 | A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 165 | AbbVie (prior sponsor, Abbott)INDUSTRY | 6 | Jan 31, 2013 | clinicaltrials |
| NCT00850499 | Phase 2 Study of VELCADE With Fludarabine in Comparison to Rituximab With Fludarabine in Follicular Lymphoma Patients Previously Treated With Rituximab | terminated | Phase 2 | 12 | Millennium Pharmaceuticals, Inc.INDUSTRY | 7 | Dec 12, 2012 | clinicaltrials |
| NCT00005053 | Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic Cancer | completed | Phase 2 | 35 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Sep 24, 2012 | clinicaltrials |
| NCT00014300 | Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme | completed | Phase 2 | 32 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 8 | Sep 24, 2012 | clinicaltrials |
| NCT00005980 | Comparison of Two Regimens of Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer | completed | Phase 2 | 116 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 18, 2012 | clinicaltrials |
| NCT00002903 | Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer | completed | Phase 2 | 25 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 14 | Jul 2, 2012 | clinicaltrials |
| NCT00754351 | Docetaxel, Gemcitabine and Bevacizumab for Metastatic Breast Cancer | completed | Phase 2 | 48 | University Hospital of CreteOTHER | 1 | Jun 28, 2012 | clinicaltrials |
| NCT00453635 | Study With Docetaxel, Carboplatin and Herceptin Versus Vinorelbine and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients | terminated | Phase 2 | 88 | Hellenic Oncology Research GroupOTHER | 1 | Mar 13, 2012 | clinicaltrials |
| NCT00926107 | Study of the mTOR Inhibitor Temsirolimus (CCI-779) to Treat Ovarian Cancer With CA125 Only Relapse | terminated | Phase 2 | 9 | Hellenic Cooperative Oncology GroupOTHER | 1 | Nov 10, 2011 | clinicaltrials |
| NCT00429559 | Topotecan in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Carcinoma | completed | Phase 1 / Phase 2 | 31 | Hellenic Oncology Research GroupOTHER | 1 | Jul 22, 2011 | clinicaltrials |
| NCT00429247 | Randomized Trial With Trastuzumab Versus Observation in Breast Cancer Patients | completed | Phase 2 | 75 | University Hospital of CreteOTHER | 1 | Jul 21, 2011 | clinicaltrials |
| NCT00614965 | Irinotecan Plus Cisplatin vs Pemetrexed Plus Cisplatin as 2nd Line in NSCLC Stage IIIB/IV | completed | Phase 2 | 124 | Hellenic Oncology Research GroupOTHER | 1 | May 23, 2011 | clinicaltrials |
| NCT00750386 | Paclitaxel and Carboplatin Combination as 1st Line Treatment in Ovarian Carcinomas | completed | Phase 1 / Phase 2 | 50 | Hellenic Oncology Research GroupOTHER | 1 | May 23, 2011 | clinicaltrials |
| NCT00790894 | Trial of Ixabepilone in Patients With HER-2 Negative Metastatic Breast Cancer (HIT)(HIT) | terminated | Phase 2 | 64 | Hellenic Cooperative Oncology GroupOTHER | 1 | May 18, 2011 | clinicaltrials |
| NCT01301248 | Cisplatin Chemoradiation With or Without Cetuximab for Locoregionally Advanced Squamous Cell Carcinomas (SCC) of the Head and Neck | unknown | Phase 2 | 80 | Theagenio Cancer HospitalOTHER_GOV | 1 | May 17, 2011 | clinicaltrials |
| NCT00401323 | Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma | completed | Phase 2 / Phase 3 | 568 | SanofiINDUSTRY | 20 | Jan 20, 2011 | clinicaltrials |
| NCT00705315 | Docetaxel/Epirubicin/Bevacizumab as First Line Therapy for Metastatic HER2 Negative Breast Cancer | completed | Phase 1 / Phase 2 | 46 | Hellenic Oncology Research GroupOTHER | 1 | Aug 19, 2010 | clinicaltrials |
| NCT00783471 | Docetaxel Intermittent-Erlotinib (Tarceva®) In Metastatic Non Small Cell Lung Cancer (NSCLC)(DOPERLO) | terminated | Phase 2 | 51 | Hellenic Cooperative Oncology GroupOTHER | 1 | Jun 16, 2010 | clinicaltrials |
| NCT01024504 | Capecitabine Plus Oxaliplatin Plus Bevacizumab as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 46 | Hellenic Oncology Research GroupOTHER | 1 | Apr 9, 2010 | clinicaltrials |
| NCT00371566 | A Study Of Lapatinib Versus Placebo Followed By Chemoradiation In Patients With Locally Advanced Head And Neck Cancer | completed | Phase 2 | 107 | GlaxoSmithKlineINDUSTRY | 5 | Apr 6, 2010 | clinicaltrials |
| NCT00101608 | Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium | completed | Phase 2 | 150 | Bristol-Myers SquibbINDUSTRY | 15 | Mar 2, 2010 | clinicaltrials |
| NCT00615758 | Erlotinib as 1st Line Treatment in NSCLC Stage IIIB/IV | completed | Phase 2 | 50 | Hellenic Oncology Research GroupOTHER | 1 | Dec 15, 2009 | clinicaltrials |
| NCT00684099 | Docetaxel/Pemetrexed as 1st Line Treatment in Patients With Non Small Cell Lung Cancer (NSCLC) | completed | Phase 1 / Phase 2 | 70 | Hellenic Oncology Research GroupOTHER | 1 | Dec 15, 2009 | clinicaltrials |
| NCT00137423 | Study Of SU011248 (Sunitinib) Given In A Continuous Daily Regimen In Patients With Advanced Renal Cell Cancer | completed | Phase 2 | 107 | PfizerINDUSTRY | 7 | Sep 30, 2009 | clinicaltrials |
| NCT00447967 | Combination of CPT-11 and LoHP vs Combination of 5-FU, Leucovorin and LoHP as 1st Line Treatment in Gastric Patients | completed | Phase 2 | 110 | Hellenic Oncology Research GroupOTHER | 1 | Sep 28, 2009 | clinicaltrials |
| NCT00428896 | A Feasibility Study With Iressa in Resistant Cytokeratin-Positive Tumor Cells Circulating in the Blood of Women With Breast Cancer | completed | Phase 2 | 24 | University Hospital of CreteOTHER | 1 | Jul 21, 2008 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials